Results

Total Results: 178 records

Showing results for "prescription".

101. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
     November 01, 2014 - About one in 10 adolescents ages 12 to 17 years use illegal drugs or prescription … The use of illegal and prescription drugs is associated with poor school performance, dropping out of … Interventions that address illegal or prescription drug use in the context of other substances, such

102. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
     November 01, 2014 - About one in 10 adolescents ages 12 to 17 years use illegal drugs or prescription … The use of illegal and prescription drugs is associated with poor school performance, dropping out of … Interventions that address illegal or prescription drug use in the context of other substances, such

103. Screening for Impaired Visual Acuity in Older Adults: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8JYDupJfG6LdRn7A6FkqXX
     March 01, 2016 - use of corrective lenses and risk of falls, includ- ing possible associations with changes in lens prescriptions

104. Screening and Interventions to Prevent Dental Caries in Children Younger Than 5 Years: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/wTL2utcBK9_czS8WDWaNT6
     December 07, 2021 - respondents shared concerns about risk of fluoride toxicity and barriers to primary care clinician fluoride prescriptions

105. 6Jfgjyjsbmc48Mj2Uksahb (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6jFgJYJSbMc48mj2uKsAhB
     October 01, 2014 - Health, United States, 2013: With Special Feature on Prescription Drugs.

106. Primary Care–Relevant Interventions to Prevent Falling in Older Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/VpT-c4bnmvHFRPyKgPwb2Z
     December 01, 2010 - without screening) includes vision correction, medication optimization or adjustment, assistive device prescription … fall-related risk factor, including vision correction, medication optimization or adjustment, assistive device prescription

107. Integrating Evidence-Based Clinical and Community Strategies to Improve Health (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfmethods.pdf
     January 01, 2020 - the Agency for Healthcare Research and Quality AHRQ) and Robert Wood Johnson Foundation as part f the Prescription

108. Archived: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening-september-2014
     September 22, 2014 - that clinicians consider expedited partner therapy, which allows for the delivery of a drug or drug prescription

109. JAMA JATS (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Nop5YpEpMybx_oNPKC76-X
     July 11, 2017 - Exercise on prescription for women aged 40-74 recruited through primary care: two year randomised controlled

110. Archived: Final Evidence Summary: Obesity in Adults: Screening and Management | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary38/obesity-in-adults-screening-and-management-2012
     October 15, 2011 - Food and Drug Administration revised its label for orlistat, 120 mg (prescription) and 60 mg (over-the-counter … Safety profile of orlistat: results of a prescription-event monitoring study.

111. Primary Care Screening for and Treatment of Depression in Pregnant and Postpartum Women: Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/svy-CsBNaoaeb7wRGFvLdW
     January 26, 2016 - than doubling of seizure occur- rence in infants of depressed women who had been provided 3 or more prescription … 2.39 [95% CI, 1.57-3.64]).75 In that study, there was no similar association among women with 1 or 2 prescription … Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based

112. Archived: Physical Activity Promotion: Behavioral Counseling, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/physical-activity-promotion-behavioral-counseling-1996
     January 01, 1996 - Guidelines for exercise testing and prescription. Philadelphia: Lea & Febiger, 1991. 11.

113. Evidence Summary: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/asymptomatic-bacteriuria-in-adults-screening
     September 24, 2019 - this shift in understanding, selection of the type of antibiotic, duration of use, and indications for prescription

114. Archived: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-in-older-adults-interventions-2018
     April 17, 2018 - A few comments also requested a recommendation on other interventions, such as reducing medication prescriptions

115. Archived: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-children-screening-july-2016
     August 09, 2016 - initiated lipid-lowering pharmacotherapy between 2005 and 2010, for an overall incidence rate of 2.6 prescriptions

116. Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
     October 01, 2011 - Food and Drug Administration revised its label for orlistat, 120 mg (prescription) and 60 mg (over-the-counter … Safety profile of orlistat: results of a prescription-event monitoring study.

117. 10th Annual Report to Congress on High-Priority Evidence Gaps (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/10th-USPSTF-Annual-Report-to-Congress.pdf
     November 01, 2020 - care–based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription

118. Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6fFns4N2J-t5EGC5BUdRuu
     October 23, 2023 - methods such as patient self- report, pill counts, adherence monitoring devices, plasma drug levels, and prescription

119. Evidence Summary: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-interventions
     September 18, 2018 - mg [10 mg twice daily]), naltrexone and bupropion (32/360 mg [16/180 mg 3 times daily]), orlistat (prescription … Safety profile of orlistat: results of a prescription-event monitoring study.

120. Archived: Final Evidence Summary: Obesity in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary39/obesity-in-children-and-adolescents-screening-2010
     January 15, 2010 - Only 1 medication (orlistat) has been approved by the US Food and Drug Administration for prescription … The US Food and Drug Administration (FDA) approved the lipase inhibitor orlistat for prescription use